HTR6 and Cognitive impairment: PF-05212377 (SAM-760), a benzimidazole derivative, and idalopirdine, an indole-based molecule, are selective 5-HT6R antagonists (Fig. 37).57 Clinical studies demonstrated that SAM-760 had no therapeutic benefits with regard to cognitive disorders; however, it showed good safety and tolerability.57,231